Abstract:
:Indoleamine 2,3-dioxygenase 1 (IDO1), which catalyzes the initial and rate-limiting step of the kynurenine pathway of tryptophan catabolism, has emerged as a key target in cancer immunotherapy because of its role in enabling cancers to evade the immune system. Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase 2 (IDO2) catalyze the same reaction and play a potential role in cancer immunotherapy. Starting from our previously discovered tryptanthrin IDO1 inhibitor scaffold, we synthesized novel N-benzyl/aryl substituted tryptanthrin derivatives and evaluated their inhibitory efficacy on IDO1, TDO, and IDO2. Most compounds showed similar high inhibitory activities on both IDO1 and TDO, which were significantly superior over that of IDO2 with magnitude difference. We showed that N-benzyl/aryl substituted tryptanthrin directly interacted with IDO1, TDO, and IDO2, significantly augmented the proliferation of T cells in vitro, blocked the kynurenine pathway, and suppressed tumor growth when administered to LLC and H22 tumor-bearing mice.
journal_name
J Med Chemjournal_title
Journal of medicinal chemistryauthors
Yang D,Zhang S,Fang X,Guo L,Hu N,Guo Z,Li X,Yang S,He JC,Kuang C,Yang Qdoi
10.1021/acs.jmedchem.9b01079subject
Has Abstractpub_date
2019-10-24 00:00:00pages
9161-9174issue
20eissn
0022-2623issn
1520-4804journal_volume
62pub_type
杂志文章abstract::Screening of our internal chemical collection against the neuropeptide Y5 (NPY Y5) receptor allowed the identification of a benzoxazine derivative 5f as a hit that showed moderate affinity (IC(50) = 300 nM). With the aim of improving the in vitro potency, a series of 2-benzoxazinone derivatives have been synthesized a...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049599u
更新日期:2005-03-24 00:00:00
abstract::Membrane-bound aminopeptidase P (AP-P) participates in the degradation of bradykinin in several vascular beds. We have developed an inhibitor of AP-P called apstatin (1) (N-[(2S, 3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]-L-prolyl-L-prolyl-L-al aninam ide); IC50,human = 2.9 microM. In the rat, apstatin can potentiate th...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9805642
更新日期:1999-07-01 00:00:00
abstract::Cancer cells generally generate higher amounts of reactive oxygen species than normal cells. On the basis of this difference, prodrugs have been developed (e.g., hydroxyferrocifen), which remain inactive in normal cells, but become activated in cancer cells. In this work we describe novel aminoferrocene-based prodrugs...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm2014937
更新日期:2012-01-26 00:00:00
abstract::Starting from the structure of the novel nonpeptidic angiotensin II antagonist DuP 753, a series of more rigid analogues was prepared by replacing the biphenyl part of DuP 753 with a naphthalene ring. Five different regioisomers (compounds 6a-e) were synthesized, and receptor binding in rat smooth muscle cell preparat...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00114a021
更新日期:1991-10-01 00:00:00
abstract::The delta-selective opioid peptide deltorphin C(H-Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2) (DEL C) was modified by para-substitution of Phe3 with halogens (F, Cl, Br, I), amino, or nitro groups. The bioactive potencies in peripheral tissues and brain receptor selectivities of these analogues depended upon the particular sub...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00103a001
更新日期:1992-12-11 00:00:00
abstract::To find Delta(8)-Delta(7) sterol isomerase (EBP) selective ligands, various arylpiperazines previously studied and structurally related to some sigma receptors ligands were preliminarily screened. Consequently, a novel series of 2- or 2,6-disubstituted (CH(3), CH(3)O, Cl, F) cis- and trans-4-(4-aryl)cyclohexyl-1-(2-py...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800965b
更新日期:2008-12-11 00:00:00
abstract::Certain structural similarities between prostaglandins with close-packed side chains and the perhydrocyclopentanophenanthrene nucleus of steroids prompted the synthesis and biological evaluation of 6beta, 17 beta-dihydroxy-5alpha-androstane-2alpha-carboxylic acid (30), its 6-deoxy derivative 28, and the corresponding ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00235a002
更新日期:1975-01-01 00:00:00
abstract::CXCL12 binds to CXCR4, promoting both chemotaxis of lymphocytes and metastasis of cancer cells. We previously identified small molecule ligands that bind CXCL12 and block CXCR4-mediated chemotaxis. We now report a 1.9 Å resolution X-ray structure of CXCL12 bound by such a molecule at a site normally bound by sY21 of C...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm501194p
更新日期:2014-11-26 00:00:00
abstract::Protein tyrosine phosphatases (PTPs) constitute a diverse family of enzymes that, together with protein tyrosine kinases, control the level of intracellular tyrosine phosphorylation, thus regulating many cellular functions. PTP1B negatively regulates insulin signaling, in part, by dephosphorylating key tyrosine residu...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm011100y
更新日期:2002-04-25 00:00:00
abstract::The dopamine D(3) receptor is recognized as a potential therapeutic target for the treatment of various neurological and psychiatric disorders. Targetting high affinity and D(3) versus D(2) receptor-preferring ligands, the partial agonist BP 897 was taken as a lead structure. Variations in the spacer and the aryl moie...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm030836n
更新日期:2003-08-28 00:00:00
abstract::A series of N-naphthylethyl amide derivatives were synthesized and evaluated as melatonin receptor ligands. The affinity of each compound for the melatonin receptor was determined by binding studies using [2-125I]iodomelatonin on ovine pars tuberalis membrane homogenates. Structure-activity relationships led to the co...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00046a006
更新日期:1994-09-30 00:00:00
abstract::Four subtypes of adenosine receptors are currently known, that is, A(1), A(2A), A(2B), and A(3) receptors. Interestingly, quite substantial species differences exist especially between human and rat A(3) receptors. As a result, ligands such as CCPA, which are very selective for the rat A(1) receptor versus the human A...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm021074j
更新日期:2003-04-10 00:00:00
abstract::A series of new HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands were designed and synthesized. Variation of phenyl substitutions at the P2 and P2' moieties significantly affected the binding affinity and antiviral potency of the inhibitors. In general, compounds w...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm1008743
更新日期:2010-11-11 00:00:00
abstract::The synthesis and antihypertensive activity of a series of novel 3-[(substituted-carbonyl)amino]-2H-1-benzopyran-4-ols, administered orally to spontaneously hypertensive rats, are described. Optimum activity in this series was observed for compounds with branched alkyl or branched alkylamino groups flanking the carbon...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00087a018
更新日期:1992-05-01 00:00:00
abstract::TYK2 is an emerging drug target for various human autoimmune diseases. However, discovery of selective TYK2 inhibitor over other JAK family members (i.e., JAK1, 2, 3) by targeting the catalytically active site (Janus Homologue 1 (JH1) domain) is challenging. This Viewpoint discusses the discovery of a series of N-meth...
journal_title:Journal of medicinal chemistry
pub_type: 评论,杂志文章
doi:10.1021/acs.jmedchem.9b01612
更新日期:2019-10-24 00:00:00
abstract::The binding structures of 11 human oxidosqualene cyclase inhibitors designed as cholesterol-lowering agents were determined for the squalene-hopene cyclase from Alicyclobacillus acidocaldarius, which is the only structurally known homologue of the human enzyme. The complexes were produced by cocrystallization, and the...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0211218
更新日期:2003-05-22 00:00:00
abstract::Fourteen structurally diverse Annonaceous acetogenins, representing the three main classes of bis-adjacent, bis-nonadjacent, and single-THF ring(s), were tested for their ability to inhibit the growth of adriamycin resistant human mammary adenocarcinoma (MCF-7/Adr) cells. This cell line is resistant to treatment with ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9700169
更新日期:1997-06-20 00:00:00
abstract::Liver-fatty acid binding protein (L-FABP) is found in high levels in enterocytes and is involved in the cytosolic solubilization of fatty acids during fat absorption. In the current studies, the interaction of L-FABP with a range of lipophilic drugs has been evaluated to explore the potential for L-FABP to provide an ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm701192w
更新日期:2008-07-10 00:00:00
abstract::A novel lysine-based trifunctional chelate 3 was designed, synthesized, and characterized and bears both a chelating moiety (CHX-A' ') for sequestering radiometals (86Y or 111In) and the near-infrared dye Cy5.5 for dual modality PET (or SPECT) and fluorescence imaging, respectively. Successful conjugation of 3 to the ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm070657w
更新日期:2007-09-20 00:00:00
abstract::Quantitative structure-activity studies were carried out on a series of N-isopropylaryl hydrazides which inhibits monoamine oxidase (MAO). The inhibitory potencies of these compounds of MAO were found to correlate with the electron-withdrawing capacity of the aryl ring substituents as estimated by both empirical Hamme...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00227a005
更新日期:1976-05-01 00:00:00
abstract::A series of esters of 6beta-hydroxynortropane and the N-methyl analogue 6beta-tropanol were synthesized and screened versus binding of an antagonist (quinuclidinyl benzilate) and an agonist (oxotremorine-M) at sites on human m(1)-, m(2)-, m(3)-, and m(4)-muscarinic receptors in transfected cell membranes and on native...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm9904001
更新日期:2000-06-29 00:00:00
abstract::Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood-brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high uptake i...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.7b00527
更新日期:2017-05-25 00:00:00
abstract::The gold(I) complexes of the general formula [Au(L(n))(PPh(3))]·xH(2)O (1-8; n = 1-8 and x = 0-1.5), where L(n) stands for a deprotonated form of the benzyl-substituted derivatives of 6-benzylaminopurine, were prepared, thoroughly characterized (elemental analyses, FT-IR, Raman and multinuclear NMR spectroscopy, ESI+ ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm201416p
更新日期:2012-05-24 00:00:00
abstract::Neuropeptide S (NPS) is the endogenous ligand of the previously orphan G-protein coupled receptor now named NPSR. The NPS-NPSR receptor system regulates important biological functions such as sleep/waking, locomotion, anxiety and food intake. Recently, exhaustive Ala scan and d-amino acid scan studies, together with s...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0706822
更新日期:2007-09-06 00:00:00
abstract::A series of 2,3-dihydrobenzofuran-5-acetic acids and related compounds was prepared as potential antiinflammatory agents. As measured by the carrageenan-induced edema method for the preliminary screening test, introduction of a methyl group alpha to the acetic acid function enhanced the antiinflammatory activity, and ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00224a020
更新日期:1976-02-01 00:00:00
abstract::The mitotic kinesin Eg5 is critical for the assembly of the mitotic spindle and is a promising chemotherapy target. Previously, we identified S-trityl-L-cysteine as a selective inhibitor of Eg5 and developed triphenylbutanamine analogues with improved potency, favorable drug-like properties, but moderate in vivo activ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm3014597
更新日期:2013-03-14 00:00:00
abstract::Molecular modeling methods have been used to design a novel series of conformationally constrained cyclic peptide inhibitors of human renin. Three goals were defined: enhanced inhibitory potency, high specificity for renin, and increased metabolic stability. Three cyclic compounds were synthesized with ring sizes 10, ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00397a003
更新日期:1988-02-01 00:00:00
abstract::A structure-guided design approach using a homology model of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) was used to improve the potency of a series of imidazopyridazine inhibitors as potential antimalarial agents. This resulted in high affinity compounds with PfCDPK1 enzyme IC50 values less tha...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm500342d
更新日期:2014-04-24 00:00:00
abstract::Homologous recombination repair (HRR), a crucial approach in DNA damage repair, is an attractive target in cancer therapy and drug design. The Bloom syndrome protein (BLM) is a 3'-5' DNA helicase that performs an important role in HRR regulation. However, limited studies about BLM inhibitors and their biological effec...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.9b00083
更新日期:2019-03-28 00:00:00
abstract::A weak, nonselective G protein-coupled receptor 120 (GPR120) agonist 10 was found by screening a series of carboxylic acids derived from the peroxisome proliferator-activated receptor gamma (PPARgamma) agonist 3. Modification based on the homology model of GPR120 led to the first GPR120-selective agonist 12. These res...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800970b
更新日期:2008-12-11 00:00:00